Full-Time

Director of Corporate Development

Corporate Development

Posted on 9/23/2025

Sonic Healthcare USA

Sonic Healthcare USA

51-200 employees

Laboratory and pathology testing services

No salary listed

Dallas, TX, USA

In Person

Category
Finance & Banking (2)
,
Required Skills
Market Research
Financial analysis
Investment Banking
Excel/Numbers/Sheets
Financial Modeling
Requirements
  • Bachelor’s degree in Business, Finance, Economics or related field; MBA preferred
  • Minimum of 7 years of experience in Corporate Development, investment banking, or financial management, with significant exposure to mergers and acquisitions
  • Exceptional corporate finance and modeling skills including the ability to independently create ad hoc financial analysis, modeling and valuation
  • Excellent communication (oral and written), interpersonal and organizational skills
  • Strong financial modeling, quantitative data analysis and negotiation skills
  • High poised executive presence with the ability to interact with senior executives and handle pressure setting with confidence
  • Ability to use a wide range of influencing skills to build consensus and alignment across the organization
  • Ability to evaluate complex problems quickly and determine creative solutions
  • Ability to build trust across functional relationships to achieve common goals
  • Excellent judgment and discretion with confidential information
  • Strong business acumen with a constructive and proactive approach to problem-solving
  • Competency in deal financial/cash flow/valuation analysis with the ability to perform rigorous and broad quantitative analysis
  • Excellent time management skills and experience managing numerous tasks simultaneously in a fast-paced environment
  • Working knowledge of IFRS/GAAP accounting standards
  • Strong proficiency in the use of MS Office Suite, including advanced Excel modeling skills
Responsibilities
  • Identifies potential acquisition targets or merger partners to align with the company's strategic goals.
  • Leads due diligence processes, assesses risks and opportunities, and negotiates terms to maximize value and minimize risks.
  • Acts as an objective advisor regarding the strategic fit, valuation, and structuring of business opportunities.
  • Develops financial models to evaluate investment opportunities and return on investment for M & A, divestitures, and joint ventures.
  • Serves as day-to-day lead across all aspects of M&A transaction processes.
  • Conducts competitive market research and analysis to identify trends, competitive and emerging opportunities for growth.
  • Assists in establishing a pipeline of potential M&A opportunities based on corporate strategic priorities.
  • Works with functional leadership (finance, legal, sales) to assess the competitive landscape, identify gaps in the current portfolio, and compare strategic alternatives.
  • Assists in creating presentation materials for executive management, potential partners and customers.
  • Identifies deal risks and work with functional leaders to assess and devise solutions.
  • Supports the development of the separation plans for divestitures and the development and implementation of transition services agreements.
  • Manages relationships with stakeholders, cross-functional departments, external partners, and industry experts to facilitate deal sourcing and execution.
  • Partners with executive leadership toward successfully executing Sonic Healthcare USA's strategic growth initiatives.
  • Ensures compliance with all legal regulatory requirements and confidentiality.
  • Performs other job-related duties as assigned.
Desired Qualifications
  • Experience in life sciences, medical or healthcare industry preferred, but not required

Sonic Healthcare USA provides laboratory testing and professional pathology services across the United States as part of Sonic Healthcare Limited, one of the world’s largest medical diagnostics groups. It operates through nine divisions and around eight thousand employees, following a federated model that puts medical leadership at the local level to ensure high-quality, community-based testing for doctors and patients. Its tests cover core diagnostic laboratory services and pathology expertise used by medical practitioners, hospitals, and community health services. The company aims to deliver precise, timely results and strong clinical partnerships to improve patient care by offering comprehensive laboratory testing and pathology support while maintaining close ties to local healthcare providers.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Austin, Texas

Founded

2014

Simplify Jobs

Simplify's Take

What believers are saying

  • Aging U.S. population drives cancer screening volumes through 2030.
  • National scaling via Sonic's sales and payer networks boosts Cairo reach.
  • Microba 19.99% stake opens gut health diagnostics expansion in 2025.

What critics are saying

  • Quest Diagnostics captures Cairo clients with faster oncology innovations within 12 months.
  • Labcorp diverts referrals using superior payer contracts in 15 months.
  • Medicare bundling slashes oncology reimbursements 20-30% post-Cairo integration.

What makes Sonic Healthcare USA unique

  • Cairo Diagnostics integrates hematology-oncology testing for comprehensive reports.
  • First major U.S. acquisition since 2021 targets high-margin oncology segment.
  • Bundled diagnostics from Cairo command premiums in competitive pathology market.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Company News

Newswise
Aug 22nd, 2025
Sonic Healthcare USA, Inc. Announces Acquisition of Cairo Diagnostics LLC to Expand Sonic's National Hematology Oncology Testing Capabilities

Sonic Healthcare USA, Inc. announces acquisition of Cairo Diagnostics LLC to expand Sonic's national hematology oncology testing capabilities.

PR Newswire
Aug 22nd, 2025
Sonic Healthcare Acquires Cairo Diagnostics

Sonic Healthcare USA, Inc. has acquired Cairo Diagnostics LLC to enhance its national hematology oncology testing capabilities. Founded by Dr. Sherif Ibrahim, Cairo is known for its integrated oncology testing approach, combining various diagnostic methods to provide comprehensive reports. This acquisition aims to expand Sonic's reach and improve service to oncologists nationwide, offering faster and more complete diagnostic solutions.

The West Australian
Mar 20th, 2024
Sonic Healthcare beefs up Swiss presence with $202m purchase of laboratory group Dr Risch

Sonic Healthcare will beef up its presence in Switzerland with the purchase of laboratory group Dr Risch for 117 million Swiss francs ($202m).

Business News Australia
Apr 27th, 2023
Sonic announces $611m in German acquisitions in April

Australias largest pathology company has today announced its second German acquisition this month, with binding agreements signed to purchase Medical Laboratori

Australian Financial Review
Nov 28th, 2022
Sonic Healthcare acquires major stake in Luke Reid’s Microba Life Sciences gut health testing business

Microba, an ASX-listed small-cap biotech, announced on Tuesday morning that Sonic would invest $17.8 million to acquire a 19.99 per cent stake in the company at 26¢ per share.

INACTIVE